Revolution Medicines (RVMDW) FCF Margin (2019 - 2023)
Revolution Medicines (RVMDW) posted quarterly FCF Margin of 15870.89% for Q4 2023, down 1547114.0% year-over-year from N/an in Q4 2022, and down 787.19% quarter-over-quarter from 1788.89% in Q2 2023.
Revolution Medicines (RVMDW) FCF Margin (2019 - 2023) Analysis & Trends
Revolution Medicines' FCF Margin history runs 5 years deep, the most recent figure standing at 15870.89% for Q4 2023.
- In Q4 2023, FCF Margin fell 1547114.0% year-over-year to 15870.89%; the TTM figure through Sep 2024 stood at 73584.1% (down 7245026.0% YoY), while the FY2023 annual figure was 3049.94%, down 240933.0% from the prior year.
- FCF Margin for Q4 2023 stood at 15870.89%, down from 1788.89% in the prior quarter.
- The five-year high for FCF Margin was 86.52% in Q4 2019, with the low at 15870.89% in Q4 2023.
- The 5-year median for FCF Margin is 399.75% (2022), against an average of 1459.21%.
- The sharpest annual moves came in 2022 and 2023: FCF Margin surged 176516 bps in 2022, then sank 1547114 bps in 2023.
- Revolution Medicines' FCF Margin stood at 86.52% in 2019, then slumped by 264 bps to 314.55% in 2020, then slumped by 36 bps to 427.0% in 2021, then grew by 6 bps to 399.75% in 2022, then plunged by 3870 bps to 15870.89% in 2023.
- Business Quant data shows RVMDW's FCF Margin at 15870.89% in Q4 2023, 1788.89% in Q2 2023, and 900.13% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -15,870.89% |
| Jun 30, 2023 | -1,788.89% |
| Mar 31, 2023 | -900.13% |
| Dec 31, 2022 | -399.75% |
| Sep 30, 2022 | -1,536.38% |
| Jun 30, 2022 | -642.08% |
| Mar 31, 2022 | -729.40% |
| Dec 31, 2021 | -427.00% |
| Sep 30, 2021 | -3,301.54% |
| Jun 30, 2021 | -353.41% |
| Mar 31, 2021 | -402.97% |
| Dec 31, 2020 | -314.55% |
| Sep 30, 2020 | -208.40% |
| Jun 30, 2020 | -209.79% |
| Mar 31, 2020 | -242.98% |
| Dec 31, 2019 | -86.52% |
| Sep 30, 2019 | -120.35% |
| Jun 30, 2019 | -93.66% |
| Mar 31, 2019 | -96.23% |